Palmitic Acid-Modified Poly-l-Lysine for Non-Viral Delivery of Plasmid DNA to Skin Fibroblasts
Authors:
- 3 March 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 8 (4) , 1059-1063
Abstract
Palmitic acid conjugates of poly-l-lysine (PLL-PA) were prepared, and their ability to deliver plasmid DNA into human skin fibroblasts was evaluated in vitro. The conjugates were capable of condensing a 4.7 kb plasmid DNA into 50−200 nm particles (mean ± SD = 112 ± 34 nm), which were slightly smaller than the particles formed by PLL (mean ± SD = 126 ± 51 nm). Both PLL and PLL-PA were readily taken up by the cells, but PLL-PA delivered the plasmid DNA into a higher proportion of cells. DNA delivery was found to be reduced by endocytosis inhibitor Brefeldin A, suggesting an active mechanism of particle uptake. Using enhanced green fluorescent protein (EGFP) as a reporter gene, PLL-PA was found to give the highest number of EGFP-positive cells among several carriers tested, including polyethyleneimine, Lipofectamine-2000, and an adenovirus. Although some carriers gave a higher percentage of EGFP-positive cells than PLL-PA, they were also associated with higher toxicities. We conclude that PLL-PA is a promising gene carrier for non-viral modification of human fibroblasts.Keywords
This publication has 29 references indexed in Scilit:
- Transduction Efficiency of Pantropic Retroviral Vectors Is Controlled by the Envelope Plasmid to Vector Plasmid RatioBiotechnology Progress, 2008
- Polymers for gene delivery across length scalesNature Materials, 2006
- RGD Conjugation to Polyethyleneimine Does Not Improve DNA Delivery to Bone Marrow Stromal CellsBiomacromolecules, 2006
- Artificial viruses: a nanotechnological approach to gene deliveryNature Reviews Drug Discovery, 2006
- Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteinsMolecular Therapy, 2005
- Lipid-modified proteins as biomarkers for cardiovascular disease: a reviewBiomarkers, 2005
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003
- Modified Linear Polyethylenimine−Cholesterol Conjugates for DNA ComplexationBioconjugate Chemistry, 2003
- Bone marrow stromal cells as a genetic platformfor systemic delivery of therapeutic proteins in vivo: human factor IX modelThe Journal of Gene Medicine, 2002
- Brefeldin A and the endocytic pathway Possible implications for membrane traffic and sortingFEBS Letters, 1992